CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 90 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $162,000 | +38.5% | 20,978 | +18.8% | 0.02% | -5.3% |
| Q3 2020 | $117,000 | +25.8% | 17,660 | +57.6% | 0.02% | +35.7% |
| Q2 2020 | $93,000 | -47.5% | 11,208 | -53.3% | 0.01% | -54.8% |
| Q3 2019 | $177,000 | -63.7% | 23,998 | +39.7% | 0.03% | -57.5% |
| Q1 2018 | $488,000 | -30.2% | 17,178 | -55.4% | 0.07% | -35.4% |
| Q3 2017 | $699,000 | +239.3% | 38,485 | +221.9% | 0.11% | +135.4% |
| Q1 2017 | $206,000 | – | 11,956 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |